Annals of Pharmacotherapy · 2003 · 103 citations · 14 references
MedicineDermatologyPathologyDermatopathologyHistopathologyHypersensitivityDrug-induced Skin ReactionsImmunopathology Of SkinInflammatory DermatosesInflammatory Disease PathologyInflammatory Skin DiseasesInflammatory Skin DisordersCutaneous Drug EruptionsCutaneous Drug ReactionsDrug-induced Lichenoid EruptionDrug-induced Skin EruptionsHistologic ExaminationHistopathologic ExaminationLichenoid DermatitisPsoriasiform Dermatitis
OBJECTIVE: To report a case of psoriasiform eruption induced by infliximab. CASE SUMMARY: A 46-year-old woman with enterocutaneous fistula secondary to Crohn's disease developed pruriginous, erythematous, desquamative plaques on her elbows, knees, hands, and buttocks after receiving the second and third doses of intravenous infliximab. Histologic examination showed a lichenoid pattern. No new cutaneous lesions appeared after cessation of infliximab therapy. DISCUSSION: Several cutaneous reactions secondary to infliximab, a monoclonal antibody against tumor necrosis factor-alfa, have been described. Psoriasiform dermatitis has not been reported as a cutaneous reaction to infliximab, but there have been several previous reports of psoriasiform dermatitis secondary to other drugs. An objective causality assessment revealed that the adverse event was probable. CONCLUSIONS: This is the first report of a clinico-pathologic dissociated pattern of cutaneous reaction showing a histopathologic picture of lichenoid dermatitis resulting from infliximab treatment.
14
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Umesh Chaudhari, Pat Romano, LD Mulcahy et al. · The Lancet · 2001 · 904 citations